LISATA THERAP.INC.DL-001 (8NE) — Defensive Interval Ratio
LISATA THERAP.INC.DL-001 (8NE) has a Defensive Interval Ratio of 0 days as of December 2025. Defensive assets of €0.00 (cash €-, short-term investments €0.00, receivables €0.00) cover 0 days of daily cash needs of €8.41K/day. See LISATA THERAP.INC.DL-001 working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
LISATA THERAP.INC.DL-001 Defensive Interval Ratio (2021–2025)
This chart shows how LISATA THERAP.INC.DL-001's Defensive Interval Ratio has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the ratio stands at 0 days, meaning defensive assets of €0.00 can fund 0 days of operations without new revenue. See how leveraged is LISATA THERAP.INC.DL-001's balance sheet to measure how much of total assets are equity-financed.
Annual Defensive Interval Ratio for LISATA THERAP.INC.DL-001 (2021–2025)
The table below presents the year-by-year Defensive Interval Ratio for LISATA THERAP.INC.DL-001 from 2021 to 2025, covering 5 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see 8NE market cap.
| Year | DIR (days) | Defensive Assets (EUR) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 0 days | €0.00 | €8.41K/day | €- | €0.00 | ▼ -1036 days |
| 2024 | 1036 days | €15.94 Million | €15.38K/day | €- | €15.04 Million | ▼ -511 days |
| 2023 | 1548 days | €27.94 Million | €18.05K/day | €- | €27.94 Million | ▼ -572 days |
| 2022 | 2120 days | €37.07 Million | €17.49K/day | €- | €37.07 Million | ▼ -3555 days |
| 2021 | 5675 days | €70.32 Million | €12.39K/day | €- | €70.32 Million | — |